Magnetar Financial LLC Uni Qure N.V. Transaction History

Magnetar Financial LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$45.06 - $67.74 $276,082 - $415,042	-6,127 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$40.01 - $73.97 $245,141 - $453,214	6,127 New	6,127 $291,000
Q4 2019 Feb 13, 2020	SELL	$37.13 - $74.62 $258,833 - $520,176	-6,971 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$39.36 - $76.8 $274,378 - $535,372	6,971 New	6,971 $274,000

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Magnetar Financial LLC with notifications on news.